Vis enkel innførsel

dc.contributor.authorSundheim, Leif
dc.contributor.authorLillegaard, Inger Therese L.
dc.contributor.authorFæste, Christiane Kruse
dc.contributor.authorBrantsæter, Anne Lise
dc.contributor.authorBrodal, Guro
dc.contributor.authorEriksen, Gunnar Sundstøl
dc.date.accessioned2017-12-18T11:10:15Z
dc.date.available2017-12-18T11:10:15Z
dc.date.created2017-04-11T14:56:26Z
dc.date.issued2017-02-04
dc.identifier.citationSundheim, L.; Lillegaard, I.T.; Fæste, C.K.; Brantsæter, A.-L.; Brodal, G.; Eriksen, G.S. Deoxynivalenol Exposure in Norway, Risk Assessments for Different Human Age Groups. Toxins 2017, 9, 46.nb_NO
dc.identifier.issn2072-6651
dc.identifier.urihttp://hdl.handle.net/11250/2472431
dc.description.abstractDeoxynivalenol (DON) is the most common mycotoxin in Norwegian cereals, and DON is detected in most samples of crude cereal grain and cereal food commodities such as flour, bran, and oat flakes. The Norwegian Scientific Committee for Food Safety assessed the risk for adverse effects of deoxynivalenol (DON) in different age groups of the domestic population. This review presents the main results from the risk assessment, supplemented with some recently published data. Impairment of the immune system together with reduced feed intake and weight gain are the critical effects of DON in experimental animals on which the current tolerable daily intake was established. Based on food consumption and occurrence data, the mean exposure to DON in years with low and high levels of DON in the flour, respectively, were in the range of or up to two times the Tolerable Daily Intake (TDI) in 1-year-old infants and 2-year-old children. In years with high mean DON concentration, the high (95th-percentile) exposure exceeded the TDI by up to 3.5 times in 1-, 2- , 4-, and 9-year-old children. The assessment concluded that exceeding the TDI in infants and children is of concern. The estimated dietary DON intakes in adolescent and adult populations are in the range of the TDI or below, and are not a health concern. Acute human exposure to DON is not of concern in any age group.nb_NO
dc.language.isoengnb_NO
dc.publisherMDPI AGnb_NO
dc.rightsNavngivelse-DelPåSammeVilkår 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-sa/4.0/deed.no*
dc.titleDeoxynivalenol Exposure in Norway, Risk Assessments for Different Human Age Groupsnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.rights.holder© 2017 by the authors; licensee MDPI, Basel, Switzerlandnb_NO
dc.source.volume9nb_NO
dc.source.journalToxinsnb_NO
dc.source.issue2nb_NO
dc.identifier.doi10.3390/toxins9020046
dc.identifier.cristin1464869
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-DelPåSammeVilkår 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-DelPåSammeVilkår 4.0 Internasjonal